HPR142 Measuring Impact of HTA on Patient Access to New Medicines in NHS England: A Comparison of Public Health Insurance Funding Restrictions and Patient Uptake for New Medicines across England, France, Germany, and the United States
Abstract
Authors
S McKeown R Kane